Viatrexx-Lymph 1 — Class II drug recall D-0337-2020
Terminated recall by 8046255 Canada Inc. DBA Viatrexx, reported 2019-11-20, distributed nationwide. Lack of Assurance of Sterility: products manufactured in a manner than cannot guarantee its sterility.
| Recall number | D-0337-2020 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | 8046255 Canada Inc. DBA Viatrexx, Beloeil, N/A, Canada |
| Recall initiated | 2019-10-15 |
| Classified | 2019-11-14 |
| Reported by FDA | 2019-11-20 |
| Terminated | 2020-12-10 |
| Distributed | Nationwide (US) |
| Quantity | 3 vials |
| Reason classes | sterility |
| NDC | 73069-0310-41 |
| Lot numbers | 19-S00017, 2020 |
| Model numbers | VSPC0370 |
Product
Viatrexx-Lymph 1, 10 mL Sterile multi-dose vial, Rx only, Viatrexx Bio Incorporated, Newark, DE, USA, 19713, Item: VSPC0370, NDC 73069-310-41.
Reason for recall
Lack of Assurance of Sterility: products manufactured in a manner than cannot guarantee its sterility.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0337-2020. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.